Patent details

EP2922872 Title: BISPECIFIC EGFR/C-MET ANTIBODIES

Basic Information

Publication number:
EP2922872
PCT Application Number:
US2013071288
Type:
European Patent Granted for LU
Legal Status:
In force
Application number:
EP138565924
PCT Publication Number:
WO2014081954
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
BISPECIFIC EGFR/C-MET ANTIBODIES
French Title of Invention:
ANTICORPS EGFR/C-MET BISPÉCIFIQUES
German Title of Invention:
BISPEZIFISCHE EGFR/C-MET-ANTIKÖRPER
SPC Number:
LUC00257

Dates

Filing date:
21/11/2013
Grant date:
10/10/2018
EP Publication Date:
30/09/2015
PCT Publication Date:
30/05/2014
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
10/10/2018
EP B1 Publication Date:
10/10/2018
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
21/11/2033
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
03/10/2018
 
 

Name:
Janssen Biotech, Inc.
Address:
800/850 Ridgeview Drive, Horsham, PA 19044, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
17/10/2018
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
PARREN, Paul
Address:
Netherlands (NL)

2

Name:
MOORES, Sheri
Address:
United States (US)

3

Name:
CHIU, Mark
Address:
United States (US)

4

Name:
NEIJSSEN, Joost
Address:
Netherlands (NL)

5

Name:
SCHUURMAN, Janine
Address:
Netherlands (NL)

Priority

1

Priority Number:
201261728912 P
Priority Date:
21/11/2012
Priority Country:
United States (US)

2

Priority Number:
201361782550 P
Priority Date:
14/03/2013
Priority Country:
United States (US)

3

Priority Number:
201361809541 P
Priority Date:
08/04/2013
Priority Country:
United States (US)

4

Priority Number:
201361864717 P
Priority Date:
12/08/2013
Priority Country:
United States (US)

5

Priority Number:
201361892797 P
Priority Date:
18/10/2013
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/437; A61K 31/4545; A61K 31/517; A61K 31/5377; A61K 33/24; A61K 39/395; A61K 45/06; A61P 35/00; C07K 16/00; C07K 16/28;

Publication

European Patent Bulletin

1

Issue number:
201841
Publication date:
10/10/2018
Description:
Grant (B1)

2

Issue number:
201846
Publication date:
14/11/2018
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
01/12/2025
Annual Fee Number:
13
Annual Fee Amount:
180 Euro
Expected Payer:
Last Annual Fee Payment Date:
13/11/2024
Last Annual Fee Paid Number:
12
Last Annual Fee Paid Amount:
165 Euro
Payer:
CPA GLOBAL THE IP PLATFORM
Filing date Document type Number of pages
17/10/2018 Power Of Attorney 1
02/11/2018 Outgoing Correspondence 1